NI Chamber Puts Galen President & MD, Dr Dennise Broderick under the Spotlight
Craigavon, N.I., 7 Oct 2019 – Dr. Dennise Broderick, President and Managing Director of global speciality pharmaceutical company, Galen, was the first member to participate in Northern Ireland Chamber of Commerce and Industry’s CEO Spotlight Series.
Supported by KPMG, the series, which was formally launched on Thursday 3rd October, aims to inspire business growth in local companies through exchanging leadership stories of successful entrepreneurs and senior managers. Read More
One of the Irish companies featured in our inaugural “Good Spirits” event, The Muff Liquor Company, has launched a crowdfunding campaign selling shares of the company through a company called Crowdcube.
The Muff Liquor Company sold 24,000 bottles in its first 14 months, won gold at the World Gin Masters competition in Hong Kong & secured listings with one of the largest drinks distributors to the UK. It seeks to expand its presence in Asia where the craft spirits market will have a compound annual growth rate of 5.4%.
Click HERE to read more and secure your shares of this dynamic company.
Almac’s unique gene expression report enables cancer researchers to discover exciting new insights claraT report now includes all ten Hallmarks of Cancer to aid novel Biomarker Discovery
Craigavon, N.I., 26 September 2019 – Almac Diagnostic Services, a member of the Almac Group, will launch the complete version of claraT at the ESMO Congress in Barcelona on 27th September. The Almac claraT Total mRNA Report content has expanded considerably from the initial version launched the previous year at the ESMO Congress. The complete version now includes 92 gene expression signatures, 100 single gene drug targets and over 7,000 additional biology linked genes, categorised by all 10 Hallmarks of Cancer.
Almac Pharma Services Achieves Unprecedented Global Regulatory Milestone
Three successful regulatory inspections completed in two weeks
Craigavon, U.K., 25 Sep 2019 Almac Pharma Services, part of the global contract pharmaceutical development and manufacturing organisation, the Almac Group, has announced the successful completion of three global regulatory GMP inspections across three facilities in the space of just two weeks.
The UK MHRA conducted a routine GMP audit at the company’s Charnwood, UK facility. The 230,000ft2 site, based in Loughborough, was acquired by Almac in 2015 and provides GMP development and manufacturing of solid oral dose clinical trial materials and small scale commercial volumes. The three day inspection of the site’s quality systems resulted in no critical or major findings.
BREXIT ON THE MENU AS IRISH BUSINESS CHAMBER HOSTS NORTHERN IRISH DIPLOMAT
What happens next with Brexit is far from clear. The outcome is a moving target.
It’s one man’s job to take the long view, to inform Northern Irish government officials of the range of possibilities, depending on that eventual outcome.
Dr. Andrew McCormick, director of general international relations, is Northern Ireland’s senior civil servant. He spoke before the Irish American Business Chamber & Network in Philadelphia recently to share what he knows—about Brexit’s potential impact on the peace process and how the lingering political uncertainties might affect the border between Northern Ireland and the Republic, along with the impact on the economy and U.S. businesses that have headquarters or operations in the north.
In a conversation before the roundtable, McCormick explained his mission during his stateside tour of Irish organizations.